AlpalifeBio

Woburn, United States

AlpalifeBio specializes in VHH discovery, nanobody drug R&D, and provides products for various biochemical applications.

$9.8M raised

Sep 2025

Series A

Top Investors

Golden Rain BogorNanling FundLivzon MabpharmGalaxy Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AlpalifeBio raised?

AlpalifeBio has raised $9.8M in total funding. The most recent round was Series A. The last funding was announced in September 2025.

Who are AlpalifeBio's investors?

AlpalifeBio's investors include Golden Rain Bogor, Nanling Fund, Livzon Mabpharm, Galaxy Capital.

Where is AlpalifeBio headquartered?

AlpalifeBio is headquartered in Woburn, United States.

What does AlpalifeBio do?

AlpalifeBio specializes in VHH discovery, nanobody drug R&D, and provides products for various biochemical applications.

What stage is AlpalifeBio at?

AlpalifeBio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 9, 2025.

MLA

"AlpalifeBio — Funding & Investors." VCBacked, September 9, 2025, https://www.vcbacked.co/company/alpalifebio. Accessed July 1, 2026.

APA

VCBacked. (2025). AlpalifeBio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/alpalifebio

Wikipedia (cite web)

{{cite web |title=AlpalifeBio — Funding & Investors |url=https://www.vcbacked.co/company/alpalifebio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 9, 2025.